Touchcef SB 500mg/250mg Injection
Marketer
Meditouch Wellness
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Touchcef SB 500mg/250mg Injection
Cefixime/Sulbactam 500mg/250mg injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication solely under a healthcare provider's guidance. Strictly adhere to the prescribed dosage schedule; complete the entire course regardless of symptom improvement. Premature cessation may compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Report any worsening symptoms immediately. Seek immediate medical attention for allergic reactions such as rash, itching, swelling, or breathing difficulties. Inform your doctor about all current medications, including those for pre-existing conditions. Pregnant or lactating individuals must consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Prioritize rest, nutrition, and hydration for optimal recovery. Your physician may order blood tests and other diagnostics to monitor treatment response.
Uses of Touchcef SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Touchcef SB 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Touchcef SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Touchcef SB 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Touchcef SB 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Touchcef SB 500mg/250mg Injection, offer a dual-action approach to bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by overcoming bacterial resistance mechanisms, thus bolstering its antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Touchcef SB 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Touchcef SB, 500mg/250mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are currently insufficient.
Breast feedingCAUTION
The administration of Touchcef SB 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Touchcef SB 500mg/250mg Injection may cause drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Touchcef SB 500mg/250mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable medication, Touchcef SB 500mg/250mg, requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Touchcef SB 500mg/250mg Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Touchcef SB 500mg/250mg Injection :
Omit a scheduled dose of Touchcef SB 500mg/250mg Injection? Seek your physician's advice.
Facts to Know About Touchcef SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently